| Literature DB >> 32352528 |
Takahiro Matsuo1, Gautam A Deshpande2,3, Hiroko Arioka2, Daiki Kobayashi2,4,5.
Abstract
Entities:
Year: 2020 PMID: 32352528 PMCID: PMC7193327 DOI: 10.1001/jamanetworkopen.2020.5120
Source DB: PubMed Journal: JAMA Netw Open ISSN: 2574-3805
Baseline Characteristics of Residents and Non–Health Care Practitioner Controls
| Characteristic | Value, Mean (SD) | ||
|---|---|---|---|
| Residents (n = 281) | Controls (n = 562) | ||
| Male, No. (%) | 191 (68.0) | 382 (68.0) | >.99 |
| Age, y | 25.5 (1.9) | 25.5 (1.9) | >.99 |
| Height, cm | 169.0 (8.7) | 168.0 (8.0) | .93 |
| Weight, kg | 61.2 (10.8) | 60.5 (10.3) | .81 |
| Body mass index | 21.3 (2.6) | 21.3 (2.6) | >.99 |
| Body fat, % | 19.2 (4.7) | 20.4 (5.2) | .001 |
| White blood cell count, × 109/L | 5.9 (1.5) | 5.7 (1.4) | .96 |
| Hemoglobin, g/dL | 14.2 (1.4) | 14.3 (1.3) | .07 |
| Total protein, g/dL | 7.3 (0.4) | 7.2 (0.3) | .92 |
| Albumin, g/dL | 4.6 (0.3) | 4.6 (0.2) | .36 |
| Total bilirubin, mg/dL | 0.9 (0.4) | 0.9 (0.4) | .91 |
| Aspartate aminotransferase, IU/L | 23.8 (62.9) | 19.7 (6.2) | .93 |
| Alanine aminotransferase, IU/L | 18.9 (22.4) | 21.1 (15.7) | .05 |
| Gamma-glutamyl transpeptidase, IU/L | 22.0 (18.3) | 25.1 (24.3) | .03 |
| Alkaline phosphatase, IU/L | 182.0 (52.1) | 185.8 (56.9) | .19 |
| Total cholesterol, mg/dL | 172.7 (26.4) | 173.1 (28.2) | .42 |
| High-density lipoprotein, mg/dL | 66.6 (14.1) | 59.4 (13.6) | >.99 |
| Low-density lipoprotein, mg/dL | 90.9 (24.3) | 98.3 (26.7) | .001 |
| Triglycerides, mg/dL | 56.8 (26.4) | 72.6 (43.4) | .001 |
| Uric acid, mg/dL | 5.4 (1.3) | 5.4 (1.3) | .53 |
| Glycated hemoglobin, % | 5.2 (0.3) | 5.2 (0.3) | .63 |
| Creatinine, mg/dL | 0.8 (0.2) | 0.8 (0.1) | .49 |
| Systolic blood pressure, mm Hg | 119 (14.2) | 112.7 (13.1) | >.99 |
| Diastolic blood pressure, mm Hg | 66.8 (8.5) | 70.2 (9.3) | >.99 |
| Current smoking, No. (%) | 2 (0.7) | 160 (28.5) | .001 |
| Insufficient sleep, No. (%) | 69 (25.0) | 254 (45.7) | .001 |
| Alcohol, No. (%) | |||
| Rarely | 212 (75.4) | 311 (55.3) | .001 |
| Occasional | 17 (6.1) | 59 (10.5) | |
| Nearly daily | 52 (18.5) | 192 (34.2) | |
| Exercise, times/wk, No. (%) | |||
| Seldom | 114 (40.6) | 266 (47.3) | .001 |
| 1-2 | 128 (45.6) | 210 (37.4) | |
| 3-5 | 29 (10.3) | 49 (8.7) | |
| Nearly daily | 10 (3.6) | 37 (6.6) | |
SI conversion factors: To convert albumin to g/L, multiply by 10.0; alanine aminotransferase to μkat/L, multiply by 0.0167; alkaline phosphatase to μkat/L, multiply by 0.0167; aspartate aminotransferase to μkat/L, multiply by 0.0167; cholesterol to mmol/L, multiply by 0.0259; creatinine to μmol/L, multiply by 88.4; gamma-glutamyl transpeptidase to μkat/L, multiply by 0.0167; hemoglobin to g/L, multiply by 10.0; glycated hemoglobin to proportion of total hemoglobin, multiply by 0.01; total bilirubin to μmol/L, multiply by 17.104; total protein to g/L, multiply by 10.0; triglycerides to mmol/L, multiply by 0.0113; uric acid to mmol/L, multiply by 0.0595.
Body mass index is calculated as weight in kilograms divided by height in meters squared.
Comparison by Multivariate Analysis of Clinical Parameters Between Physicians and Non–Health Care Practitioners at 1-Year Follow-up
| Parameter | Change between residents and non–health care practitioners, adjusted mean difference (95% CI) | |
|---|---|---|
| Body fat, % | 0.25 (0.03 to 0.48) | .03 |
| Body mass index | 0.04 (−0.06 to 0.13) | .45 |
| Low-density lipoprotein, mg/dL | 1.93 (0.36 to 3.49) | .02 |
| High-density lipoprotein, mg/dL | −3.01 (−3.86 to −2.17) | .001 |
| Triglycerides, mg/dL | 4.1 (−3.20 to 11.3) | .27 |
| Systolic blood pressure, mm Hg | −0.85 (−1.84 to 0.15) | .10 |
| Diastolic blood pressure, mm Hg | −1.43 (−2.14 to −0.71) | .001 |
SI conversion factors: To convert cholesterol to mmol/L, multiply by 0.0259; triglycerides to mmol/L, multiply by 0.0113.
Body mass index is calculated as weight in kilograms divided by height in meters squared.